A randomised, double-blind, placebo-controlled study of AIMSPRO in secondary progressive multiple sclerosis (MS) .

Trial Profile

A randomised, double-blind, placebo-controlled study of AIMSPRO in secondary progressive multiple sclerosis (MS) .

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Caprine serum (Primary)
  • Indications Multiple sclerosis; Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Aug 2011 Planned End Date changed from 1 Oct 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Status changed from recruiting to completed, according to information in a Daval International media release.
    • 28 Oct 2010 Status changed from completed to recruiting as reported by ISRCTN: Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top